Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Traws Pharma (TRAW) over the last 12 years, with Q3 2025 value amounting to -$62000.0.

  • Traws Pharma's Cash from Financing Activities changed N/A to -$62000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year increase of 1560.05%. This contributed to the annual value of $34.0 million for FY2024, which is N/A changed from last year.
  • Per Traws Pharma's latest filing, its Cash from Financing Activities stood at -$62000.0 for Q3 2025.
  • Traws Pharma's Cash from Financing Activities' 5-year high stood at $35.6 million during Q1 2021, with a 5-year trough of -$62000.0 in Q3 2025.
  • For the 3-year period, Traws Pharma's Cash from Financing Activities averaged around $9.8 million, with its median value being $1.6 million (2025).
  • The largest annual percentage gain for Traws Pharma's Cash from Financing Activities in the last 5 years was 63377.48% (2021), contrasted with its biggest fall of 11254.48% (2021).
  • Quarter analysis of 3 years shows Traws Pharma's Cash from Financing Activities stood at -$35000.0 in 2021, then surged by 57177.14% to $20.0 million in 2024, then tumbled by 100.31% to -$62000.0 in 2025.
  • Its last three reported values are -$62000.0 in Q3 2025, $3.1 million for Q2 2025, and $13000.0 during Q1 2025.